Pizzi Marina, Spano Pierfranco
Division of Pharmacology and Experimental Therapeutics, Department of Biomedical Sciences and Biotechnologies, School of Medicine, University of Brescia, I 25123, Italy.
Eur J Pharmacol. 2006 Sep 1;545(1):22-8. doi: 10.1016/j.ejphar.2006.06.027. Epub 2006 Jun 16.
The nuclear transcription factors kappaB (NF-kappaB) function as key regulators of physiological processes in the central nervous system. Aberrant regulation of NF-kappaB can underlie neurological disorders associated with neurodegeneration. A large number of studies have reported a dual role of NF-kappaB in regulating neuron survival in pathological conditions. A recent progress in understanding the mechanisms responsible for opposite effects elicited by NF-kappaB in brain dysfunctions arises from the identification of diverse NF-kappaB complexes specifically involved in the mechanism of neuronal cell death or cell survival. We here discuss the latest findings and consider the therapeutic potential of targeting distinct NF-kappaB complexes for the treatment of neurodegenerative disorders and memory dysfunctions.
核转录因子κB(NF-κB)是中枢神经系统生理过程的关键调节因子。NF-κB的异常调节可能是与神经退行性变相关的神经系统疾病的基础。大量研究报道了NF-κB在病理条件下调节神经元存活中的双重作用。对NF-κB在脑功能障碍中产生相反作用的机制的最新认识进展来自于对专门参与神经元细胞死亡或细胞存活机制的不同NF-κB复合物的鉴定。我们在此讨论最新发现,并考虑针对不同的NF-κB复合物治疗神经退行性疾病和记忆功能障碍的治疗潜力。